Amylyx Pharmaceuticals, Inc. - AMLX
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
· Updating…
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Oct 07, 2026 | — | S | D | 30,000.0 | 27.6968 | 830,904.0 | 782,881.0 | View | |
| Sep 14, 2026 | Chief Medical Officer | S | D | 2,081.0 | 33.0919 | 68,864.24 | 278,064.0 | View | |
| Sep 14, 2026 | Chief Medical Officer | S | D | 7,947.0 | 32.2139 | 256,003.86 | 280,145.0 | View | |
| Sep 14, 2026 | Chief Financial Officer | S | D | 1,042.0 | 33.2302 | 34,625.87 | 233,625.0 | View | |
| Sep 14, 2026 | Chief Financial Officer | S | D | 9,768.0 | 32.2681 | 315,194.8 | 234,667.0 | View | |
| Sep 14, 2026 | Chief Legal Officer | S | D | 11.0 | 33.34 | 366.74 | 190,838.0 | View | |
| Sep 14, 2026 | Chief Legal Officer | S | D | 9,525.0 | 32.4556 | 309,139.59 | 190,849.0 | View | |
| Sep 14, 2026 | Co-Chief Executive Officer | S | D | 1,439.0 | 33.1552 | 47,710.33 | 3,613,056.0 | View | |
| Sep 14, 2026 | Co-Chief Executive Officer | S | D | 29,025.0 | 32.1293 | 932,552.93 | 3,614,495.0 | View | |
| Sep 14, 2026 | Co-Chief Executive Officer | S | D | 919.0 | 33.1488 | 30,463.75 | 3,613,123.0 | View | |
| Sep 14, 2026 | Co-Chief Executive Officer | S | D | 29,545.0 | 32.1557 | 950,040.16 | 3,614,042.0 | View | |
| Sep 02, 2026 | — | M | D | 25,000.0 | 0.0 | 0.0 | 0.0 | View | |
| Sep 02, 2026 | — | M | D | 25,000.0 | 0.0 | 0.0 | 0.0 | View | |
| Sep 02, 2026 | — | M | A | 25,000.0 | 5.05 | 126,250.0 | 116,900.0 | View | |
| Sep 02, 2026 | — | M | A | 25,000.0 | 1.76 | 44,000.0 | 91,900.0 | View | |
| Aug 20, 2026 | Chief Financial Officer | A | A | 22,807.0 | 0.0 | 0.0 | 244,435.0 | View | |
| Aug 20, 2026 | Co-Chief Executive Officer | A | A | 60,039.0 | 0.0 | 0.0 | 3,643,520.0 | View | |
| Aug 20, 2026 | Chief Legal Officer | A | A | 21,284.0 | 0.0 | 0.0 | 200,374.0 | View | |
| Aug 20, 2026 | Chief Medical Officer | A | A | 22,807.0 | 0.0 | 0.0 | 288,092.0 | View | |
| Aug 20, 2026 | Co-Chief Executive Officer | A | A | 60,039.0 | 0.0 | 0.0 | 3,643,587.0 | View | |
| Jul 13, 2026 | Chief Legal Officer | S | D | 15,000.0 | 17.6081 | 264,121.5 | 179,090.0 | View | |
| Jul 13, 2026 | Chief Legal Officer | S | D | 15,000.0 | 18.3164 | 274,746.0 | 194,090.0 | View | |
| Jun 08, 2026 | — | A | A | 24,372.0 | 0.0 | 0.0 | 24,372.0 | View | |
| Jun 08, 2026 | — | A | A | 24,372.0 | 0.0 | 0.0 | 24,372.0 | View | |
| Jun 08, 2026 | — | A | A | 24,372.0 | 0.0 | 0.0 | 24,372.0 | View | |
| Jun 08, 2026 | — | A | A | 24,372.0 | 0.0 | 0.0 | 24,372.0 | View | |
| Jun 08, 2026 | — | A | A | 24,372.0 | 0.0 | 0.0 | 24,372.0 | View | |
| May 26, 2026 | — | P | A | 3,800.0 | 13.51 | 51,338.0 | 66,900.0 | View |